Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason D Roberts

Showing results (131-140 of 152) with videos related to

Pageof 16
Sort By:
European Heart Journal|June 29, 2022
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculatorPaloma Jordà, Laurens P Bosman, Alessio Gasperetti, et al.
European Heart Journal|May 31, 2019
Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrestChristian van der Werf, Krystien V Lieve, J Martijn Bos, et al.
JAMA Cardiology|April 8, 2026
RBM20 Truncating Variants and Human CardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
Heart Rhythm|April 8, 2024
An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardiaAvani Lamba, Thomas M Roston, Puck J Peltenburg, et al.
JAMA|June 20, 2024
A Clinical Diagnostic Test for Calcium Release Deficiency SyndromeMingke Ni, Ziv Dadon, Julian O M Ormerod, et al.
Circulation|December 7, 2021
An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular TachycardiaPuck J Peltenburg, Dania Kallas, Johan M Bos, et al.
Circulation|October 27, 2023
Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular TachycardiaAuke T Bergeman, Krystien V V Lieve, Dania Kallas, et al.
Circulation|July 23, 2020
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of <i>CASQ2</i>-Catecholaminergic Polymorphic Ventricular TachycardiaKevin Ng, Erron W Titus, Krystien V Lieve, et al.
European Heart Journal|January 9, 2024
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and EuropeRichard T Carrick, Corrado De Marco, Alessio Gasperetti, et al.
Circulation|January 17, 2020
An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic ConditionJason D Roberts, S Yukiko Asaki, Andrea Mazzanti, et al.
Pageof 16

Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
European Heart Journal|June 29, 2022
Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculatorPaloma Jordà, Laurens P Bosman, Alessio Gasperetti, et al.
European Heart Journal|May 31, 2019
Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrestChristian van der Werf, Krystien V Lieve, J Martijn Bos, et al.
JAMA Cardiology|April 8, 2026
RBM20 Truncating Variants and Human CardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
Heart Rhythm|April 8, 2024
An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardiaAvani Lamba, Thomas M Roston, Puck J Peltenburg, et al.
JAMA|June 20, 2024
A Clinical Diagnostic Test for Calcium Release Deficiency SyndromeMingke Ni, Ziv Dadon, Julian O M Ormerod, et al.
Circulation|December 7, 2021
An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular TachycardiaPuck J Peltenburg, Dania Kallas, Johan M Bos, et al.
Circulation|October 27, 2023
Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular TachycardiaAuke T Bergeman, Krystien V V Lieve, Dania Kallas, et al.
Circulation|July 23, 2020
An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of <i>CASQ2</i>-Catecholaminergic Polymorphic Ventricular TachycardiaKevin Ng, Erron W Titus, Krystien V Lieve, et al.
European Heart Journal|January 9, 2024
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and EuropeRichard T Carrick, Corrado De Marco, Alessio Gasperetti, et al.
Circulation|January 17, 2020
An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic ConditionJason D Roberts, S Yukiko Asaki, Andrea Mazzanti, et al.
Pageof 16